Company Filing History:
Years Active: 1989
Title: Kathryn E Fisher: Innovator in Bacillus Strains
Introduction
Kathryn E Fisher is a notable inventor based in Bethesda, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of Bacillus strains with reduced extracellular protease levels. Her innovative work has implications for the expression and secretion of heterologous polypeptides and proteins.
Latest Patents
Kathryn holds a patent for "Bacillus strains with reduced extracellular protease levels." This patent describes the production of Bacillus strains that have reduced levels of extracellular protease by replacing the native chromosomal DNA sequence comprising the gene for an extracellular protease, such as subtilisin, with a partially homologous DNA sequence that includes an inactivating DNA segment. This advancement allows for the use of these strains as hosts for the expression and secretion of various proteins.
Career Highlights
Kathryn is currently associated with Genex Corporation, where she continues to push the boundaries of biotechnological research. Her work has garnered attention for its potential applications in various industries, including pharmaceuticals and agriculture.
Collaborations
Kathryn collaborates with Stephen R Fahnestock, contributing to the advancement of their shared research interests and projects.
Conclusion
Kathryn E Fisher's innovative work in developing Bacillus strains has opened new avenues for biotechnological applications. Her contributions are vital to the ongoing evolution of protein expression technologies.